sk&f 81297 has been researched along with bromocriptine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, Y; Asano, Y; Kusano, E; Saito, O | 1 |
| Floresco, SB; St Onge, JR | 1 |
| Choi, DS; Choi, S; Choi, Y; Hinton, DJ; Oliveros, A; Park, JH; Prieto, ML; Ruby, CL; Vadnie, CA | 1 |
3 other study(ies) available for sk&f 81297 and bromocriptine
| Article | Year |
|---|---|
Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD.
Topics: Animals; Benzazepines; Biological Transport; Bromocriptine; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Electrochemistry; Epithelium; Kidney Cortex; Kidney Tubules, Collecting; Perfusion; Rabbits; Receptors, Dopamine; Sodium | 2001 |
Dopaminergic modulation of risk-based decision making.
Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Benzopyrans; Bromocriptine; Conditioning, Operant; Decision Making; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Naphthalenes; Oxazines; Piperazines; Pyridines; Pyrroles; Pyrrolidines; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Reinforcement Schedule; Risk; Salicylamides | 2009 |
Activation of neurotensin receptor type 1 attenuates locomotor activity.
Topics: Animals; Benzazepines; Bromocriptine; Central Nervous System Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Environment; Housing, Animal; Male; Mice, Inbred C57BL; Microinjections; Motor Activity; Muscle Strength; Neurotensin; Nucleus Accumbens; Prefrontal Cortex; Random Allocation; Receptors, Dopamine; Receptors, Neurotensin; Rotarod Performance Test | 2014 |